We found that increased IFNA17 protein expression was associated with induction of CHRM4, phosphorylated (p)-AKT, and MYCN proteins in prostate cancer cells, but decreased expression of these proteins was observed after DHT treatment (Fig. 6A). This evidence concerns the gene IFNA17 and prostate carcinoma.